Literature DB >> 29806623

Effect of the Epicardial Adipose Tissue Volume on the Prevalence of Paroxysmal and Persistent Atrial Fibrillation.

Kageyuki Oba1, Minetaka Maeda1, Gulinu Maimaituxun2, Satoshi Yamaguchi1, Osamu Arasaki1, Daiju Fukuda3, Shusuke Yagi2, Yukina Hirata2, Susumu Nishio2, Takashi Iwase2, Shoichiro Takao4, Kenya Kusunose2, Hirotsugu Yamada2, Takeshi Soeki2, Tetsuzo Wakatsuki2, Masafumi Harada5, Hiroaki Masuzaki6, Masataka Sata2, Michio Shimabukuro1,3,7.   

Abstract

BACKGROUND: Although increasing evidence suggests that epicardial adipose tissue volume (EATV) is associated with atrial fibrillation (AF), it is controversial whether there is a dose-response relationship of increasing EATV along the continuum of AF. We evaluated the effect of the EATV on the prevalence of paroxysmal AF (PAF) and persistent AF (PeAF) and the relationships with cardiac structure and functional remodeling.Methods and 
Results: Subjects who underwent multidetector computed tomography (MDCT) coronary angiography because of symptoms suggestive of coronary artery disease were divided into sinus rhythm (SR) (n=112), PAF (n=133), and PeAF (n=71) groups. The EATV index (EATV/body surface area, mL/m2) was strongly associated with the prevalence of PAF and PeAF on the model adjusted for known AF risk factors. The effect of the EATV index on the prevalence of PeAF, but not on that of PAF, was modified by the left atrial (LA) dimension, suggesting that extension of the LA dimension is related to EATV expansion in PeAF. The cutoff value of the EATV index for the prevalence was higher in PeAF than in PAF (64 vs. 55 mL/m2, P<0.01).
CONCLUSIONS: The EATV index is associated with the prevalence of PAF and PeAF, and its cutoff values are predictive for PAF and PeAF development independently of other AF risk factors.

Entities:  

Keywords:  Atrial fibrillation; Epicardial adipose tissue volume; Obesity

Mesh:

Year:  2018        PMID: 29806623     DOI: 10.1253/circj.CJ-18-0021

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  10 in total

1.  Association of Epicardial Fat with Diastolic and Vascular Functions in Children with Type 1 Diabetes.

Authors:  Faisal-Alkhateeb Ahmad; Kotb Abbass Metwalley; Ismail Lotfy Mohamad
Journal:  Pediatr Cardiol       Date:  2022-01-28       Impact factor: 1.655

Review 2.  Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions.

Authors:  Syona S Shetty; Andrew Krumerman
Journal:  Cardiovasc Diabetol       Date:  2022-06-28       Impact factor: 8.949

3.  The association between epicardial adipose tissue thickness around the right ventricular free wall evaluated by transthoracic echocardiography and left atrial appendage function.

Authors:  Satoshi Yamaguchi; Yuka Otaki; Balaji Tamarappoo; Jun Yoshida; Hiroki Ikenaga; John Friedman; Daniel Berman; Damini Dey; Takahiro Shiota
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-01       Impact factor: 2.357

Review 4.  Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.

Authors:  Ellen R Lubbers; Morgan V Price; Peter J Mohler
Journal:  Front Physiol       Date:  2018-10-22       Impact factor: 4.566

5.  Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis.

Authors:  Yingrui Li; Bin Liu; Yu Li; Xiaodong Jing; Songbai Deng; Yulin Yan; Qiang She
Journal:  Cardiovasc Diabetol       Date:  2019-01-10       Impact factor: 9.951

6.  Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.

Authors:  Milton Packer
Journal:  Cardiovasc Diabetol       Date:  2019-09-24       Impact factor: 9.951

7.  Development and Validation of a Machine Learning-Based Radiomics Model on Cardiac Computed Tomography of Epicardial Adipose Tissue in Predicting Characteristics and Recurrence of Atrial Fibrillation.

Authors:  Min Yang; Qiqi Cao; Zhihan Xu; Yingqian Ge; Shujiao Li; Fuhua Yan; Wenjie Yang
Journal:  Front Cardiovasc Med       Date:  2022-03-03

Review 8.  The Predictive Value of Epicardial Fat Tissue Volume in the Occurrence and Development of Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Qiankun Fan; Yinge Zhan; Mingqi Zheng; Fangfang Ma; Lishuang Ji; Lei Zhang; Gang Liu
Journal:  Cardiol Res Pract       Date:  2022-09-29       Impact factor: 1.990

Review 9.  Characterization, Pathogenesis, and Clinical Implications of Inflammation-Related Atrial Myopathy as an Important Cause of Atrial Fibrillation.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-04-03       Impact factor: 5.501

Review 10.  Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.